title: [Treatment of migraine with vasopressin].
abstract: Clinicophysiological studies were performed in 186 patients with different variants of migraine. Of these, 153 received a course of treatment with the neuropeptide 8-arginine vasopressin. The pain paroxysms were reduced in intensity and duration in 87% of the cases in which also the cerebral hemodynamics, psychoemotional state, autonomic vascular conditions and working capacities improved. Prophylactic courses yielded positive results in 63 patients. The therapeutic effectiveness of 8-arginine vasopressin, and the simplicity of its administration without untoward effects and complications allowed us to recommend the drug to use in migraines, especially during the attacks.
authors.forename: V S
authors.initials: VS
authors.lastname: Lobzin
authors.forename: N S
authors.initials: NS
authors.lastname: Vasil'ev
mesh_terms: D000293:Adolescent; D000328:Adult; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D004453:Echoencephalography; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy*; D010992:Plethysmography, Impedance; D013817:Thermography
chemical_list: D001127:Arginine Vasopressin
vernacular_title: Lechenie migreni vazopressinom.